CLINICAL TRIALS PROFILE FOR RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

All Clinical Trials for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00137501 ↗	Two Dose Regimens of Nifedipine for the Management of Preterm Labor	Terminated	American University of Beirut Medical Center	Phase 3	2003-05-01	Preterm birth is one of the most important causes of perinatal morbidity and mortality worldwide. Prevention and treatment of preterm labor is important, not as an end in itself, but as a means of reducing adverse events for the neonate. A wide range of tocolytics, drugs used to suppress uterine contractions, have been tried. Magnesium sulfate (MgSO4) is the most widely used tocolytic at the American University of Beirut Medical Center despite the fact that an effective tocolytic role of MgSO4 has never been established. Moreover, the currently available data are suggestive of deleterious fetal effects of MgSO4 in the setting of preterm labor to the extent that some authorities are recommending abandoning it for routine use as a tocolytic therapy. Calcium channel blockers have the ability to inhibit contractility in smooth muscle cells. Consequently, nifedipine has emerged as an effective and rather safe alternative tocolytic agent for the management of preterm labor after several studies have shown that the use of nifedipine in comparison with other tocolytics is associated with a more frequent successful prolongation of pregnancy, resulting in significantly fewer admissions of newborns to the neonatal intensive care unit, and is associated with a lower incidence of respiratory distress syndrome. The unequivocal impact of this method of tocolysis on short term postponement of delivery and the opportunity that this provides for affecting in-utero transfer and steroid administration has prompted many investigators to recommend focusing future trials on testing different dose regimens of nifedipine. To the best of the investigators' knowledge, no study comparing two different dose regimens of nifedipine has been previously published in the literature. The objective of their study is to compare the effectiveness of a high versus a low dose regimen in a total of 200 patients admitted with the diagnosis of preterm labor between 24 and 34 weeks of gestation. In addition, the investigators' study will try to assess the safety profile of the 2 dose regimens on the mother and the neonate by assessing a selected number of outcome variables. The data generated will be used to change their protocol for managing patients presenting with threatened preterm delivery and will fill the existing gap regarding the most effective and safest dose regimen of nifedipine in such patients.
NCT00290173 ↗	Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor	Completed	Ministry of Science, Education and Sport, Republic of Croatia	N/A	1969-12-31	This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.
NCT00290173 ↗	Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor	Completed	University of Zagreb	N/A	1969-12-31	This is a trial comparing the efficacy of oral ritodrine in the form of sustained release capsules for the maintenance of uterine quiescence after successfully treated episode of threatened preterm labor.
NCT00679705 ↗	Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study Itself	Completed	University Hospital, Ghent	Phase 1	2008-05-01	This trial will consist of two parts: A pilot study in a three-way cross over trial to determine the highest well tolerated dose of Ritodrine (Pre-Par®), the impact of Atosiban (Tractocile®) on the hemodynamics and hence the design of the final study. The final study is planned as a three-way crossover trial to investigate and compare the cardiovascular effects of Ritodrine, Atosiban and placebo to relate those effects to the pharmacokinetics of Ritodrine and Atosiban (PK/PD modelling).

Clinical Trial Conditions for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Placenta Previa	1
Pregnancy	1
Preterm Birth	1
Preterm Labor	1

Condition MeSH

Condition MeSH for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Obstetric Labor, Premature	7
Premature Birth	4
Placenta Previa	1
Respiratory Distress Syndrome, Newborn	1

Clinical Trial Locations for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
Egypt	4
Belgium	1
Korea, Republic of	1
Croatia	1
United States	1

Trials by US State

Trials by US State for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
New York	1

Clinical Trial Progress for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	6
Unknown status	2
Terminated	2

Clinical Trial Sponsors for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Assiut University	3
University Hospital, Ghent	1
Tawam Hospital	1

Sponsor Type

Sponsor Type for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Other	11